BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lalau JD, Arnouts P, Sharif A, De Broe ME. Metformin and other antidiabetic agents in renal failure patients. Kidney Int. 2015;87:308-322. [PMID: 24599253 DOI: 10.1038/ki.2014.19] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Schernthaner G, Schernthaner-reiter MH. Risk of metformin use in patients with T2DM and advanced CKD. Nat Rev Endocrinol 2015;11:697-9. [DOI: 10.1038/nrendo.2015.132] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
2 Pino RM, Singh J. Appropriate Clinical Use of Lactate Measurements. Anesthesiology 2021;134:637-44. [PMID: 33332524 DOI: 10.1097/ALN.0000000000003655] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Guo X, Li X, Yang W, Liao W, Shen JZ, Ai W, Pan Q, Sun Y, Zhang K, Zhang R, Qiu Y, Dai Q, Zheng H, Guo S. Metformin Targets Foxo1 to Control Glucose Homeostasis. Biomolecules 2021;11:873. [PMID: 34208360 DOI: 10.3390/biom11060873] [Reference Citation Analysis]
4 Stanton RC. Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations? Am J Kidney Dis 2015;66:193-5. [PMID: 25960301 DOI: 10.1053/j.ajkd.2015.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 De Broe ME, Jouret F. Does metformin do more benefit or harm in chronic kidney disease patients? Kidney Int 2020;98:1098-101. [PMID: 33126974 DOI: 10.1016/j.kint.2020.04.059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hu Y, Lei M, Ke G, Huang X, Peng X, Zhong L, Fu P. Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease-A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:559446. [PMID: 33117278 DOI: 10.3389/fendo.2020.559446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bell S, Farran B, McGurnaghan S, McCrimmon RJ, Leese GP, Petrie JR, McKeigue P, Sattar N, Wild S, McKnight J, Lindsay R, Colhoun HM, Looker H. Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study. BMC Nephrol 2017;18:163. [PMID: 28526011 DOI: 10.1186/s12882-017-0579-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
8 Goonoo MS, Morris R, Raithatha A, Creagh F. Republished: Metformin-associated lactic acidosis: reinforcing learning points. Drug Ther Bull 2021;59:124-7. [PMID: 34031180 DOI: 10.1136/dtb.2021.235608rep] [Reference Citation Analysis]
9 Chen CC, Ko Y, Chen CH, Hung YJ, Wei TE, Chang TH, Ke SS, Kuo KN, Chen C. RElationship between Metformin use and lactic Acidosis In advanced chronic kidNey Disease: The REMIND-TMU study: Metformin-Associated Lactic Acidosis in Advanced CKD. Am J Med Sci 2022:S0002-9629(22)00166-5. [PMID: 35483434 DOI: 10.1016/j.amjms.2022.01.026] [Reference Citation Analysis]
10 Betônico CC, Titan SM, Correa-Giannella ML, Nery M, Queiroz M. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clinics (Sao Paulo) 2016;71:47-53. [PMID: 26872083 DOI: 10.6061/clinics/2016(01)08] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
11 Vest LS, Koraishy FM, Zhang Z, Lam NN, Schnitzler MA, Dharnidharka VR, Axelrod D, Naik AS, Alhamad TA, Kasiske BL, Hess GP, Lentine KL. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data. Clin Transplant 2018;32:e13302. [PMID: 29851159 DOI: 10.1111/ctr.13302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
12 Scheen AJ. Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment. Evid Based Med 2015;20:115. [PMID: 25827139 DOI: 10.1136/ebmed-2015-110184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kajbaf F, De Broe ME, Lalau J. Therapeutic Concentrations of Metformin: A Systematic Review. Clin Pharmacokinet 2016;55:439-59. [DOI: 10.1007/s40262-015-0323-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 12.0] [Reference Citation Analysis]
14 Lalau JD, Kajbaf F. Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels. Int J Endocrinol 2014;2014:717198. [PMID: 25587274 DOI: 10.1155/2014/717198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Posma RA, Frøslev T, Jespersen B, van der Horst ICC, Touw DJ, Thomsen RW, Nijsten MW, Christiansen CF. Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study. Ann Intensive Care 2020;10:36. [PMID: 32219580 DOI: 10.1186/s13613-020-00652-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Greco P, Regolisti G, Maggiore U, Ferioli E, Fani F, Locatelli C, Parenti E, Maccari C, Gandolfini I, Fiaccadori E. Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury. J Nephrol 2019;32:297-306. [PMID: 30523561 DOI: 10.1007/s40620-018-00562-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
17 Wooley AC, Kerr JL. Monitoring Patients on Metformin: Recent Changes and Rationales. J Pharm Technol 2018;34:28-36. [PMID: 34860984 DOI: 10.1177/8755122517747295] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Maccallum L, Senior PA. Safe Use of Metformin in Adults With Type 2 Diabetes and Chronic Kidney Disease: Lower Dosages and Sick-Day Education Are Essential. Canadian Journal of Diabetes 2019;43:76-80. [DOI: 10.1016/j.jcjd.2018.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
19 Venos ES, Sigal RJ. My patient's diabetic kidney disease has progressed to stage 4; should I discontinue metformin? Can J Diabetes 2014;38:296-9. [PMID: 25284696 DOI: 10.1016/j.jcjd.2014.07.225] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Angioi A, Cabiddu G, Conti M, Pili G, Atzeni A, Matta V, Cao R, Floris M, Songini M, Mulas MF, Rosner M, Pani A. Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up. BMC Nephrol 2018;19:77. [PMID: 29609531 DOI: 10.1186/s12882-018-0875-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
21 Shah AD, Mchargue C, Yee J, Rushakoff RJ. Intravenous Contrast In Patients With Diabetes On Metformin: New Common Sense Guidelines. Endocrine Practice 2016;22:502-5. [DOI: 10.4158/ep151123.co] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Futatsugi A, Masuo Y, Kawabata S, Nakamichi N, Kato Y. L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides. Journal of Pharmacy and Pharmacology 2016;68:1160-9. [DOI: 10.1111/jphp.12574] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
23 Lalau J, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm: LALAU et al . Diabetes Obes Metab 2017;19:1502-12. [DOI: 10.1111/dom.12974] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 12.4] [Reference Citation Analysis]
24 Boucaud-Maitre D, Ropers J, Porokhov B, Altman JJ, Bouhanick B, Doucet J, Girardin E, Kaloustian E, Lassmann Vague V, Emmerich J. Lactic acidosis: relationship between metformin levels, lactate concentration and mortality. Diabet Med 2016;33:1536-43. [PMID: 26882092 DOI: 10.1111/dme.13098] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
25 Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14:1992-2000. [PMID: 25307034 DOI: 10.1111/ajt.12850] [Cited by in Crossref: 289] [Cited by in F6Publishing: 232] [Article Influence: 36.1] [Reference Citation Analysis]
26 Chowdhury TA, Srirathan D, Abraham G, Oei EL, Fan SL, Mccafferty K, Yaqoob MM. Could metformin be used in patients with diabetes and advanced chronic kidney disease?: CHOWDHURY et al. Diabetes Obes Metab 2017;19:156-61. [DOI: 10.1111/dom.12799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Neven E, Vervaet B, Brand K, Gottwald-hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau J, Kamel S, De Broe ME, D’haese PC. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Kidney International 2018;94:102-13. [DOI: 10.1016/j.kint.2018.01.027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
28 Park J, Hwang SY, Jo IJ, Jeon K, Suh GY, Lee TR, Yoon H, Cha WC, Sim MS, Carriere KC, Yeon S, Shin TG. Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock. Shock 2017;47:582-7. [PMID: 27792125 DOI: 10.1097/SHK.0000000000000782] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
29 Corremans R, Neven E, Maudsley S, Leysen H, De Broe ME, D’haese PC, Vervaet BA, Verhulst A. Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats. Kidney International 2022. [DOI: 10.1016/j.kint.2022.01.037] [Reference Citation Analysis]
30 Trinkley KE, Anderson HD, Nair KV, Malone DC, Saseen JJ. Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis. Ther Adv Chronic Dis. 2018;9:179-190. [PMID: 30181847 DOI: 10.1177/2040622318779760] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
31 Rajasurya V, Anjum H, Surani S. Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes. Cureus 2019;11:e4739. [PMID: 31355098 DOI: 10.7759/cureus.4739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Mulyani WRW, Sanjiwani MID, Sandra, Prabawa IPY, Lestari AAW, Wihandani DM, Suastika K, Saraswati MR, Bhargah A, Manuaba IBAP. Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:559-68. [PMID: 32161482 DOI: 10.2147/DMSO.S232133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Emwas AH, Alghrably M, Dhahri M, Sharfalddin A, Alsiary R, Jaremko M, Faa G, Campagna M, Congiu T, Piras M, Piludu M, Pichiri G, Coni P, Lachowicz JI. Living with the enemy: from protein-misfolding pathologies we know, to those we want to know. Ageing Res Rev 2021;70:101391. [PMID: 34119687 DOI: 10.1016/j.arr.2021.101391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
34 Rutledge CA, Kaufman BA, Dezfulian C, Elmer J. Metformin Protects Against Cardiac and Renal Damage in Diabetic Cardiac Arrest Patients. Resuscitation 2022. [DOI: 10.1016/j.resuscitation.2022.03.017] [Reference Citation Analysis]
35 Kuo CC, Yeh HC, Chen B, Tsai CW, Lin YS, Huang CC. Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study. Medicine (Baltimore) 2015;94:e2175. [PMID: 26705203 DOI: 10.1097/MD.0000000000002175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Goonoo MS, Morris R, Raithatha A, Creagh F. Metformin-associated lactic acidosis: reinforcing learning points. BMJ Case Rep 2020;13:e235608. [PMID: 32878828 DOI: 10.1136/bcr-2020-235608] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Bennis Y, Bodeau S, Batteux B, Gras-champel V, Masmoudi K, Maizel J, De Broe ME, Lalau J, Lemaire-hurtel A. A Study of Associations Between Plasma Metformin Concentration, Lactic Acidosis, and Mortality in an Emergency Hospitalization Context. Critical Care Medicine 2020;48:e1194-202. [DOI: 10.1097/ccm.0000000000004589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
38 Evans M, Dejager S, Schweizer A, Foley JE. Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease? Diabetes Ther 2015;6:1-5. [PMID: 25783754 DOI: 10.1007/s13300-015-0104-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
39 Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes 2016; 7(17): 354-395 [PMID: 27660695 DOI: 10.4239/wjd.v7.i17.354] [Cited by in CrossRef: 201] [Cited by in F6Publishing: 147] [Article Influence: 33.5] [Reference Citation Analysis]
40 Salem A, Saad A, El-naa MM, El-feky GS, El-ghlban S, El-torgoman AEAE, Attia MF, Whitehead DC. Miglitol-PMO nanoparticles, an alpha-glucosidase inhibitor, has prolonged action on blood glucose level in diabetic rats. Journal of Drug Delivery Science and Technology 2022;72:103388. [DOI: 10.1016/j.jddst.2022.103388] [Reference Citation Analysis]
41 Posma RA, Absalom AR, Touw DJ, van der Horst IC, Nijsten MW. Metformin and lactic acidosis during shock: just the tip of the iceberg? Crit Care 2016;20:158. [PMID: 27246047 DOI: 10.1186/s13054-016-1333-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Imam TH. Changes in metformin use in chronic kidney disease. Clin Kidney J 2017;10:301-4. [PMID: 28616207 DOI: 10.1093/ckj/sfx017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
43 Pérez-sáez MJ, Marín-casino M, Pascual J. Treating posttransplantation diabetes mellitus. Expert Opinion on Pharmacotherapy 2015;16:1435-48. [DOI: 10.1517/14656566.2015.1039983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Keltanen T, Nenonen T, Ketola RA, Ojanperä I, Sajantila A, Lindroos K. Post-mortem analysis of lactate concentration in diabetics and metformin poisonings. Int J Legal Med 2015;129:1225-31. [DOI: 10.1007/s00414-015-1256-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Chow E, Poon EW, Fok BS, Chan JC, Tomlinson B. CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. Pharmgenomics Pers Med 2019;12:397-401. [PMID: 32099442 DOI: 10.2147/PGPM.S226200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Newland DM, Edwards AR, Hall RC, Maxwell PR. Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant Recipients. Diabetes Spectr 2018;31:167-76. [PMID: 29773937 DOI: 10.2337/ds17-0029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
47 Walz L, Jönsson AK, Ahlner J, Östgren CJ, Druid H. Metformin - Postmortem fatal and non-fatal reference concentrations in femoral blood and risk factors associated with fatal intoxications. Forensic Sci Int 2019;303:109935. [PMID: 31491622 DOI: 10.1016/j.forsciint.2019.109935] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Corremans R, Vervaet BA, D'Haese PC, Neven E, Verhulst A. Metformin: A Candidate Drug for Renal Diseases. Int J Mol Sci 2018;20:E42. [PMID: 30583483 DOI: 10.3390/ijms20010042] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
49 Regolisti G, Antoniotti R, Fani F, Greco P, Fiaccadori E. Treatment of Metformin Intoxication Complicated by Lactic Acidosis and Acute Kidney Injury: The Role of Prolonged Intermittent Hemodialysis. Am J Kidney Dis 2017;70:290-6. [PMID: 28223003 DOI: 10.1053/j.ajkd.2016.12.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
50 Hung S, Chang Y, Liu J, Kuo K, Chen Y, Hsu C, Tarng D. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. The Lancet Diabetes & Endocrinology 2015;3:605-14. [DOI: 10.1016/s2213-8587(15)00123-0] [Cited by in Crossref: 88] [Cited by in F6Publishing: 35] [Article Influence: 12.6] [Reference Citation Analysis]
51 Piel S, Ehinger JK, Chamkha I, Frostner EÅ, Sjövall F, Elmér E, Hansson MJ. Bioenergetic bypass using cell-permeable succinate, but not methylene blue, attenuates metformin-induced lactate production. Intensive Care Med Exp 2018;6:22. [PMID: 30069806 DOI: 10.1186/s40635-018-0186-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
52 Langsford D, Steinberg A, Dwyer KM. Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient. Drugs Aging 2017;34:589-601. [PMID: 28718072 DOI: 10.1007/s40266-017-0478-2] [Reference Citation Analysis]
53 Weisberg LS. Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus. Clin J Am Soc Nephrol 2015;10:1476-83. [PMID: 25762524 DOI: 10.2215/CJN.10871014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
54 Smieszek A, Tomaszewski KA, Kornicka K, Marycz K. Metformin Promotes Osteogenic Differentiation of Adipose-Derived Stromal Cells and Exerts Pro-Osteogenic Effect Stimulating Bone Regeneration. J Clin Med. 2018;7. [PMID: 30486321 DOI: 10.3390/jcm7120482] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
55 Clemens KK, Liu K, Shariff S, Schernthaner G, Tangri N, Garg AX. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013. Diabetes Obes Metab 2016;18:607-14. [PMID: 26939711 DOI: 10.1111/dom.12658] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
56 Bjällmark A, Bazzi M, Karlsson M, Krakys E, Kihlberg J. Radiology departmental policy compliance with Swedish guidelines regarding post-contrast acute kidney injury for examinations with iodinated contrast media. Radiography (Lond) 2021:S1078-8174(21)00048-1. [PMID: 34023227 DOI: 10.1016/j.radi.2021.04.009] [Reference Citation Analysis]
57 Gopoju R, Panangipalli S, Kotamraju S. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis. Free Radical Biology and Medicine 2018;118:85-97. [DOI: 10.1016/j.freeradbiomed.2018.02.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
58 Huijink TM, Venema LH, Posma RA, de Vries NJ, Westerkamp AC, Ottens PJ, Touw DJ, Nijsten MW, Leuvenink HGD. Metformin Preconditioning and Postconditioning to Reduce Ischemia Reperfusion Injury in an Isolated Ex Vivo Rat and Porcine Kidney Normothermic Machine Perfusion Model. Clin Transl Sci 2021;14:222-30. [PMID: 32702185 DOI: 10.1111/cts.12846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Doenyas-Barak K, Beberashvili I, Marcus R, Efrati S. Lactic acidosis and severe septic shock in metformin users: a cohort study. Crit Care 2016;20:10. [PMID: 26775158 DOI: 10.1186/s13054-015-1180-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
60 Moioli A, Maresca B, Manzione A, Napoletano AM, Coclite D, Pirozzi N, Punzo G, Menè P. Metformin associated lactic acidosis (MALA): clinical profiling and management. J Nephrol 2016;29:783-9. [PMID: 26800971 DOI: 10.1007/s40620-016-0267-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
61 Muller C, Dimitrov Y, Imhoff O, Richter S, Ott J, Krummel T, Bazin-kara D, Chantrel F, Hannedouche T. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations? Journal of Diabetes and its Complications 2016;30:675-80. [DOI: 10.1016/j.jdiacomp.2016.01.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
62 Dissanayake AM, Wheldon MC, Ahmed J, Hood CJ. Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy. Kidney Int Rep 2017;2:705-12. [PMID: 29318219 DOI: 10.1016/j.ekir.2017.03.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
63 De broe M, Kajbaf F, Lalau J. Renoprotective Effects of Metformin. Nephron 2018;138:261-74. [DOI: 10.1159/000481951] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
64 Penfornis A, Fiquet B, Blicklé JF, Dejager S. Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study. Diabetes Metab Syndr Obes 2015;8:303-13. [PMID: 26170705 DOI: 10.2147/DMSO.S83897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
65 Sharif A, Cohney S. Post-transplantation diabetes-state of the art. Lancet Diabetes Endocrinol. 2016;4:337-349. [PMID: 26632096 DOI: 10.1016/s2213-8587(15)00387-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 6.4] [Reference Citation Analysis]
66 Wong CKH, Lui DTW, Lui AYC, Low MCH, Kwok ACY, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort. Front Endocrinol 2022;13:810914. [DOI: 10.3389/fendo.2022.810914] [Reference Citation Analysis]
67 Hashemi P, Pezeshki S. Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance. Immunopharmacol Immunotoxicol 2021;43:265-70. [PMID: 34057870 DOI: 10.1080/08923973.2021.1925294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Migdalis IN, Papanas N, Ioannidis IM, Sotiropoulos AE, Raptis AE, Dimitriadis GD, On Behalf Of The Hellenic Diabetic Nephropathy Study Hdns. Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece. J Clin Med 2021;10:2104. [PMID: 34068380 DOI: 10.3390/jcm10102104] [Reference Citation Analysis]
69 Bhat JA, Masoodi SR, Bhat MH, Bhat H, Ahmad PO, Sood M. Lactic Acidosis in Diabetic Ketoacidosis: A Marker of Severity or Alternate Substrate for Metabolism. Indian J Endocrinol Metab 2021;25:59-66. [PMID: 34386396 DOI: 10.4103/ijem.IJEM_753_20] [Reference Citation Analysis]
70 Corchia A, Wynckel A, Journet J, Moussi Frances J, Skandrani N, Lautrette A, Zafrani L, Lewandowski E, Reboul P, Vrigneaud L, Djerada Z, Rieu P. Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study. Clinical Toxicology 2020;58:375-82. [DOI: 10.1080/15563650.2019.1648816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
71 Pimentel AL, Bauer AC, Camargo JL. Renal posttransplantation diabetes mellitus: An overview. Clinica Chimica Acta 2015;450:327-32. [DOI: 10.1016/j.cca.2015.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]